These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. 14-3-3 protein binds to insulin receptor substrate-1, one of the binding sites of which is in the phosphotyrosine binding domain. Ogihara T; Isobe T; Ichimura T; Taoka M; Funaki M; Sakoda H; Onishi Y; Inukai K; Anai M; Fukushima Y; Kikuchi M; Yazaki Y; Oka Y; Asano T J Biol Chem; 1997 Oct; 272(40):25267-74. PubMed ID: 9312143 [TBL] [Abstract][Full Text] [Related]
44. Raptor binds the SAIN (Shc and IRS-1 NPXY binding) domain of insulin receptor substrate-1 (IRS-1) and regulates the phosphorylation of IRS-1 at Ser-636/639 by mTOR. Tzatsos A J Biol Chem; 2009 Aug; 284(34):22525-34. PubMed ID: 19561084 [TBL] [Abstract][Full Text] [Related]
45. Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells. Weigert C; Kron M; Kalbacher H; Pohl AK; Runge H; Häring HU; Schleicher E; Lehmann R Mol Endocrinol; 2008 Dec; 22(12):2729-40. PubMed ID: 18927238 [TBL] [Abstract][Full Text] [Related]
46. Serine phosphorylation proximal to its phosphotyrosine binding domain inhibits insulin receptor substrate 1 function and promotes insulin resistance. Liu YF; Herschkovitz A; Boura-Halfon S; Ronen D; Paz K; Leroith D; Zick Y Mol Cell Biol; 2004 Nov; 24(21):9668-81. PubMed ID: 15485932 [TBL] [Abstract][Full Text] [Related]
47. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin. Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661 [TBL] [Abstract][Full Text] [Related]
49. PKCdelta and mTOR interact to regulate stress and IGF-I induced IRS-1 Ser312 phosphorylation in breast cancer cells. Mingo-Sion AM; Ferguson HA; Koller E; Reyland ME; Van Den Berg CL Breast Cancer Res Treat; 2005 Jun; 91(3):259-69. PubMed ID: 15952059 [TBL] [Abstract][Full Text] [Related]
50. Modulation of insulin-stimulated degradation of human insulin receptor substrate-1 by Serine 312 phosphorylation. Greene MW; Sakaue H; Wang L; Alessi DR; Roth RA J Biol Chem; 2003 Mar; 278(10):8199-211. PubMed ID: 12510059 [TBL] [Abstract][Full Text] [Related]
51. Signalling pathways of insulin-like growth factor-I that are augmented by cAMP in FRTL-5 cells. Ariga M; Nedachi T; Akahori M; Sakamoto H; Ito Y; Hakuno F; Takahashi S Biochem J; 2000 Jun; 348 Pt 2(Pt 2):409-16. PubMed ID: 10816436 [TBL] [Abstract][Full Text] [Related]
52. p38 mitogen-activated protein kinase-dependent transactivation of ErbB receptor family: a novel common mechanism for stress-induced IRS-1 serine phosphorylation and insulin resistance. Hemi R; Yochananov Y; Barhod E; Kasher-Meron M; Karasik A; Tirosh A; Kanety H Diabetes; 2011 Apr; 60(4):1134-45. PubMed ID: 21386087 [TBL] [Abstract][Full Text] [Related]
53. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323 [TBL] [Abstract][Full Text] [Related]
54. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. Kim B; Cheng HL; Margolis B; Feldman EL J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124 [TBL] [Abstract][Full Text] [Related]
55. Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation. Law NC; Hunzicker-Dunn ME J Biol Chem; 2016 Feb; 291(9):4547-60. PubMed ID: 26702053 [TBL] [Abstract][Full Text] [Related]
56. Differential regulation of insulin receptor substrate-2 and mitogen-activated protein kinase tyrosine phosphorylation by phosphatidylinositol 3-kinase inhibitors in SH-SY5Y human neuroblastoma cells. Kim B; Leventhal PS; White MF; Feldman EL Endocrinology; 1998 Dec; 139(12):4881-9. PubMed ID: 9832424 [TBL] [Abstract][Full Text] [Related]
57. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance. Knowlden JM; Jones HE; Barrow D; Gee JM; Nicholson RI; Hutcheson IR Breast Cancer Res Treat; 2008 Sep; 111(1):79-91. PubMed ID: 17902048 [TBL] [Abstract][Full Text] [Related]
58. Plk1 phosphorylation of IRS2 prevents premature mitotic exit via AKT inactivation. Chen L; Li Z; Ahmad N; Liu X Biochemistry; 2015 Apr; 54(15):2473-80. PubMed ID: 25830382 [TBL] [Abstract][Full Text] [Related]
59. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Kim YB; Zhu JS; Zierath JR; Shen HQ; Baron AD; Kahn BB Diabetes; 1999 Feb; 48(2):310-20. PubMed ID: 10334307 [TBL] [Abstract][Full Text] [Related]
60. Interruption of growth hormone signaling via SHC and ERK in 3T3-F442A preadipocytes upon knockdown of insulin receptor substrate-1. Wang X; Yang N; Deng L; Li X; Jiang J; Gan Y; Frank SJ Mol Endocrinol; 2009 Apr; 23(4):486-96. PubMed ID: 19164446 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]